Trevi Therapeutics (TRVI) Insider Trading & Ownership → The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad) Free TRVI Stock Alerts $2.72 -0.13 (-4.56%) (As of 10:13 AM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Trevi Therapeutics (NASDAQ:TRVI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage27.46%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$7,977.40 Get TRVI Insider Trade Alerts Want to know when executives and insiders are buying or selling Trevi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TRVI Insider Buying and Selling by Quarter Ad Stansberry ResearchThe "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why… Trevi Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/11/2023Lisa DelfiniCFOSell785$2.02$1,585.70 9/11/2023Lisa DelfiniCFOSell711$2.20$1,564.20 8/11/2023Lisa DelfiniCFOSell682$2.36$1,609.52 7/11/2023Lisa DelfiniCFOSell687$2.34$1,607.58 6/12/2023Lisa DelfiniCFOSell610$2.64$1,610.40 (Data available from 1/1/2013 forward) TRVI Insider Trading Activity - Frequently Asked Questions Who is on Trevi Therapeutics's Insider Roster? The list of insiders at Trevi Therapeutics includes Lisa Delfini, Paul Edward Walker, and Tpg Gp A, Llc. Learn more on insiders at TRVI. What percentage of Trevi Therapeutics stock is owned by insiders? 27.46% of Trevi Therapeutics stock is owned by insiders. Learn more on TRVI's insider holdings. Which Trevi Therapeutics insiders have been selling company stock? The following insiders have sold TRVI shares in the last 24 months: Lisa Delfini ($31,845.30), and Tpg Gp A, Llc ($1,594,043.64). How much insider selling is happening at Trevi Therapeutics? Insiders have sold a total of 567,680 Trevi Therapeutics shares in the last 24 months for a total of $1,625,888.94 sold. More Insider Trading Tools from MarketBeat Related Companies: Veru Insider Transactions Gossamer Bio Insider Transactions Greenwich LifeSciences Insider Transactions Capricor Therapeutics Insider Transactions Alimera Sciences Insider Transactions Adicet Bio Insider Transactions 23andMe Insider Transactions Vaccitech Insider Transactions Atossa Therapeutics Insider Transactions Omeros Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:TRVI) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
